134 related articles for article (PubMed ID: 8475480)
1. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits.
Zawilska K; Zozulinska M; Turowiecka Z; Blahut M; Drobnik L; Vinazzer H
Thromb Res; 1993 Feb; 69(3):315-20. PubMed ID: 8475480
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
Hermida J; Montes R; Páramo JA; Rocha E
J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
4. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
[TBL] [Abstract][Full Text] [Related]
5. Hirudin in disseminated intravascular coagulation.
Nowak G; Markwardt F
Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
[TBL] [Abstract][Full Text] [Related]
6. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC).
Ishikawa A; Hafter R; Seemüller U; Gokel JM; Graeff H
Thromb Res; 1980 Aug; 19(3):351-8. PubMed ID: 7434319
[No Abstract] [Full Text] [Related]
7. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
8. Lepirudin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pharmacological studies with recombinant hirudin.
Markwardt F; Nowak G; Stürzebecher J; Vogel G
Thromb Res; 1988 Dec; 52(5):393-400. PubMed ID: 3222782
[TBL] [Abstract][Full Text] [Related]
11. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
12. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
Kouz J; Czech J; Nicolay U; Dickneite G
Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
[TBL] [Abstract][Full Text] [Related]
13. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
Hauptmann J; Brüggener E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
15. Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis.
Dickneite G; Czech J
Thromb Haemost; 1994 Jun; 71(6):768-72. PubMed ID: 7974345
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.
Esslinger HU; Haas S; Maurer R; Lassmann A; Dübbers K; Müller-Peltzer H
Thromb Haemost; 1997 May; 77(5):911-9. PubMed ID: 9184402
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with desulfato-hirudin prevents fibrin formation in lipopolysaccharide-induced shock.
Siebeck M; Spannagl M; Bichler J; Hoffmann H; Gippner-Steppert C; Jochum M
Thromb Res; 1997 Dec; 88(6):473-80. PubMed ID: 9610958
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model.
Schiffer ER; Reber G; De Moerloose P; Morel DR
Crit Care Med; 2002 Dec; 30(12):2689-99. PubMed ID: 12483060
[TBL] [Abstract][Full Text] [Related]
20. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
